Mucosal vascular addressins
The present invention relates to isolated and/or recombinant nucleic acids which encode naturally occurring primate MAdCAMs, wherein said nucleic acid encodes the polypeptide shown in FIG. 1 (SEQ ID NO:2), the polypeptide shown in FIG. 2 (SEQ ID NO:4), or the polypeptide shown in FIG. 3 (SEQ ID NO:6). The invention further relates to recombinant nucleic acid constructs, comprising a nucleic acid which encodes a naturally occurring primate MAdCAM, wherein said nucleic acid encodes a polypeptide having an amino acid sequence as set forth in FIG. 1 (SEQ ID NO:2), FIG. 2 (SEQ ID NO:4), or FIG. 3 (SEQ ID NO:6); to host cells comprising such constructs, useful for the production of recombinant proteins; the use of nucleic acids and/or proteins in assays to identify inhibitors (e.g., antagonists) of primate MAdCAM function; and to antibodies reactive with primate MAdCAM, which are useful in in vitro methods, diagnostic and/or therapeutic applications.
1. An isolated nucleic acid which encodes a naturally occurring primate MAdCAM, wherein said nucleic acid encodes the polypeptide shown in FIG. 1 (SEQ ID NO:2), the polypeptide shown in FIG. 2 (SEQ ID NO:4), or the polypeptide shown in FIG. 3 (SEQ ID NO:6).
2. The isolated nucleic acid of claim 1 , which is a recombinant nucleic acid.
3. The isolated nucleic acid of claim 1 , wherein said nucleic acid is essentially pure.
4. An isolated nucleic acid which encodes a naturally occurring primate MAdCAM, comprising a nucleotide sequence selected from the group consisting of a nucleotide sequence as shown FIG. 1 (SEQ ID NO:1), a nucleotide sequence as shown FIG. 2 (SEQ ID NO:3), a nucleotide sequence as shown FIG. 3 (SEQ ID NO:5), a portion of a nucleotide sequence shown in FIG. 1 (SEQ ID NO:1) comprising the coding sequence, a portion of a nucleotide sequence shown in FIG. 2 (SEQ ID NO:3) comprising the coding sequence and a portion of a nucleotide sequence shown in FIG. 3 (SEQ ID NO:5) comprising the coding sequence.
5. An isolated nucleic acid which encodes a naturally occurring mature primate MAdCAM encoded by any one of SEQ ID NO:1, SEQ ID NO:3 or SEQ ID NO:5.
6. A recombinant nucleic acid construct comprising a nucleic acid which encodes a naturally occurring primate MAdCAM, wherein said nucleic acid encodes a polypeptide having an amino acid sequence as set forth in FIG. 1 (SEQ ID NO:2), FIG. 2 (SEQ ID NO:4), or FIG. 3 (SEQ ID NO:6).
7. The recombinant construct of claim 6 , wherein the nucleic acid is operably linked to an expression control sequence.
8. A recombinant nucleic acid construct comprising a recombinant nucleic acid encoding a naturally occurring primate MAdCAM, wherein said nucleic acid has a nucleotide sequence selected from the group consisting of a nucleotide sequence as shown FIG. 1 (SEQ ID NO:1), a nucleotide sequence as shown FIG. 2 (SEQ ID NO:3), a nucleotide sequence as shown FIG. 3 (SEQ ID NO:5), a portion of a nucleotide sequence shown in FIG. 1 (SEQ ID NO: 1) comprising the coding sequence, a portion of a nucleotide sequence shown in FIG. 2 (SEQ ID NO: 3) comprising the coding sequence and a portion of a nucleotide sequence shown in FIG. 3 (SEQ ID NO: 5) comprising the coding sequence.
9. A host cell comprising a recombinant nucleic acid encoding a naturally occurring primate MAdCAM, wherein said nucleic acid encodes the polypeptide shown in FIG. 1 (SEQ ID NO:2), the polypeptide shown in FIG. 2 (SEQ ID NO:4), or the polypeptide shown in FIG. 3 (SEQ ID NO:6).
10. A host cell comprising a recombinant nucleic acid encoding a naturally occurring primate MAdCAM, wherein said nucleic acid comprises a nucleotide sequence selected from the group consisting of a nucleotide sequence as shown FIG. 1 (SEQ ID NO:1), a nucleotide sequence as shown FIG. 2 (SEQ ID NO:3), a nucleotide sequence as shown FIG. 3 (SEQ ID NO:5), a portion of a nucleotide sequence shown in FIG. 1 (SEQ ID NO: 1) comprising the coding sequence, a portion of a nucleotide sequence shown in FIG. 2 (SEQ ID NO: 3) comprising the coding sequence and a portion of a nucleotide sequence shown in FIG. 3 (SEQ ID NO: 5) comprising the coding sequence.